IL117969A0 - Inhibiting photodecomposition of 3-substituted-2-oxinoles - Google Patents

Inhibiting photodecomposition of 3-substituted-2-oxinoles

Info

Publication number
IL117969A0
IL117969A0 IL11796996A IL11796996A IL117969A0 IL 117969 A0 IL117969 A0 IL 117969A0 IL 11796996 A IL11796996 A IL 11796996A IL 11796996 A IL11796996 A IL 11796996A IL 117969 A0 IL117969 A0 IL 117969A0
Authority
IL
Israel
Prior art keywords
oxinoles
substituted
photodecomposition
inhibiting
inhibiting photodecomposition
Prior art date
Application number
IL11796996A
Other languages
English (en)
Inventor
Willard C Newlin Jr
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL117969A0 publication Critical patent/IL117969A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11796996A 1995-04-24 1996-04-18 Inhibiting photodecomposition of 3-substituted-2-oxinoles IL117969A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
IL117969A0 true IL117969A0 (en) 1996-08-04

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11796996A IL117969A0 (en) 1995-04-24 1996-04-18 Inhibiting photodecomposition of 3-substituted-2-oxinoles

Country Status (30)

Country Link
EP (1) EP0827399A1 (sv)
JP (1) JPH10506635A (sv)
KR (1) KR100189585B1 (sv)
CN (1) CN1053667C (sv)
AP (1) AP607A (sv)
AR (1) AR002728A1 (sv)
AU (1) AU692378B2 (sv)
BG (1) BG100531A (sv)
BR (1) BR9602024A (sv)
CO (1) CO4700418A1 (sv)
FI (1) FI973988A (sv)
HR (1) HRP960194A2 (sv)
HU (1) HU216544B (sv)
IL (1) IL117969A0 (sv)
IS (1) IS4339A (sv)
MA (1) MA23848A1 (sv)
NO (1) NO961622L (sv)
NZ (1) NZ286432A (sv)
OA (1) OA10286A (sv)
PE (1) PE34397A1 (sv)
RO (1) RO113305B1 (sv)
RU (1) RU2109510C1 (sv)
SG (1) SG64924A1 (sv)
SI (1) SI9600133A (sv)
SK (1) SK51296A3 (sv)
TR (1) TR199600300A2 (sv)
UA (1) UA42739C2 (sv)
WO (1) WO1996033701A1 (sv)
YU (1) YU25096A (sv)
ZA (1) ZA963210B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111526730B (zh) 2017-12-29 2024-02-23 卡夫食品集团品牌有限责任公司 使用天然稳定剂改善的水包油乳液的氧化稳定性

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
FI973988A0 (sv) 1997-10-17
AP9600787A0 (en) 1996-04-30
YU25096A (sh) 1998-08-14
AU5085196A (en) 1996-11-07
BG100531A (en) 1997-06-30
AP607A (en) 1997-08-27
RU2109510C1 (ru) 1998-04-27
CN1139110A (zh) 1997-01-01
EP0827399A1 (en) 1998-03-11
UA42739C2 (uk) 2001-11-15
IS4339A (is) 1996-10-25
TR199600300A2 (tr) 1996-11-21
FI973988A (sv) 1997-10-17
PE34397A1 (es) 1997-09-29
SI9600133A (en) 1996-10-31
CO4700418A1 (es) 1998-12-29
HU9601057D0 (en) 1996-06-28
OA10286A (en) 1997-09-19
AR002728A1 (es) 1998-04-29
CN1053667C (zh) 2000-06-21
HUP9601057A3 (en) 1997-05-28
KR100189585B1 (ko) 1999-06-01
KR960037656A (ko) 1996-11-19
HU216544B (hu) 1999-07-28
NZ286432A (en) 1998-05-27
ZA963210B (en) 1997-10-23
SK51296A3 (en) 1997-04-09
RO113305B1 (ro) 1998-06-30
NO961622D0 (no) 1996-04-23
HRP960194A2 (en) 1998-02-28
JPH10506635A (ja) 1998-06-30
NO961622L (no) 1996-10-25
MA23848A1 (fr) 1996-12-31
HUP9601057A2 (en) 1997-04-28
WO1996033701A1 (en) 1996-10-31
BR9602024A (pt) 1998-10-06
AU692378B2 (en) 1998-06-04
SG64924A1 (en) 1999-05-25

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
PL327569A1 (en) Promedications of thrombosin inhibitors
GB9526560D0 (en) Use of 2-Amino-Heterocycles
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
GB9719643D0 (en) Hydrate inhibition
GB9512290D0 (en) Uses of polyhexanide
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
HUP9601524A2 (en) Prodrugs of paclytaxel-derivatives
IL116924A (en) Preparation of n-aryl - and n-hetarylhydroxylamines
ZA965922B (en) Preparation of N-substituted 3-hydroxypyrazoles.
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
GB9621852D0 (en) Inhibition of scale
ZA969429B (en) Amidinohydrazones of ketones
IL117786A (en) Preparation of alpha-bisoximes
AP9600787A0 (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
GB9510563D0 (en) Well inhibition
GB9602060D0 (en) Combined shower
IL118238A0 (en) Synthesis of benzoquinolinones
HUP9903723A3 (en) Ginkgolides for inhibition of membrane expression
ZA962440B (en) Destressing of railtracks
IL115554A0 (en) Earthquake-proofing of structures
GB9514072D0 (en) Preparation of thionucleosides
IL117844A0 (en) Use of (s)-adenosyl-l-methionine
GB9503734D0 (en) Manufacture of polyanlines
LT95087A (en) Device of vibrocontrol